{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:49:38Z","timestamp":1753890578718,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>COVID-19 has evolved into a seasonal coronavirus disease, characterized by prolonged infection duration and repeated infections, significantly increasing the risk of patients developing long COVID. Our research focused on the immune responses in asymptomatic and mild cases, particularly the critical factors influencing serum immunoglobulin G (IgG) levels and their predictive value.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective analysis on data from 1939 asymptomatic or mildly symptomatic COVID-19 patients hospitalized between September 2022 and June 2023. Spearman methods were used to test the correlation between serum IgG and age, immunoglobulin M (IgM), procalcitonin (PCT), interleukin-6 (IL-6), nucleic acid conversion time, and BMI. Univariate and multivariate logistic regression analyses identified independent key factors influencing serum IgG levels, which were integrated and visualized in a nomogram. Finally, receiver operating characteristic (ROC) curves were plotted to predict the model\u2019s diagnostic performance by calculating the AUC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mild patients showed higher levels of IgG, IgM, and longer nucleic acid conversion times than asymptomatic patients, and a lower proportion of them had received \u2265 3 COVID-19 vaccine doses. Serum IgG was positively correlated with serum IgM and negatively correlated with age, PCT, IL-6, and BMI. Notably, it showed a moderate negative correlation with nucleic acid conversion time (r = -0.578, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). Logistic regression results showed that younger age, lower IL-6 levels, \u2265 3 doses of vaccine, and no comorbidities were independent predictors of serum IgG levels \u2265 21.08 g\/L. We used age, IL-6 levels, vaccine doses, and comorbidities to create a nomogram for predicting serum IgG levels, with the area under the ROC curve reaching 0.772.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Age, IL-6 levels, vaccination status, and comorbidities were independent predictors of serum IgG levels in asymptomatic or mild COVID-19 patients, facilitating risk stratification and clinical decision-making. Notably, receiving \u22653 doses of the COVID-19 vaccine was the most beneficial factor for elevated serum IgG levels.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2024.1477585","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T06:31:54Z","timestamp":1733725914000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a prediction nomogram for IgG levels among asymptomatic or mild patients with COVID-19"],"prefix":"10.3389","volume":"14","author":[{"given":"Jianying","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Pi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/ard-2022-222784","article-title":"Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update","volume":"82","author":"Aletaha","year":"2023","journal-title":"Ann. Rheumatol. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmi.2022.01.014","article-title":"Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis","volume":"28","author":"Alkodaymi","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10122608","article-title":"Risk factors of infection, hospitalization and death from SARS-coV-2: A population-based cohort study","volume":"10","author":"Castilla","year":"2021","journal-title":"J. Clin. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.2147\/IDR.S418629","article-title":"Clinico-epidemiological laboratory findings of COVID- 19 positive patients in a hospital in Saudi Arabia","volume":"16","author":"Elhag","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013881.pub2","article-title":"Interleukin-6 blocking agents for treating COVID-19: a living systematic review","volume":"6","author":"Ghosn","year":"2023","journal-title":"Cochrane. Database. Syst. Rev."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12040913","article-title":"The aftermath of COVID-19: exploring the long-term effects on organ systems","volume":"12","author":"Golzardi","year":"2024","journal-title":"Biomedicines"},{"key":"B8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.immuni.2022.05.005","article-title":"Antibody-mediated neutralization of SARS-coV-2","volume":"55","author":"Gruell","year":"2022","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1590\/1806-9282.20210389","article-title":"Immunogenicity after CoronaVac vaccination","volume":"67","author":"Guzel","year":"2021","journal-title":"Rev. Assoc. Med. Bras. (1992)."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection","volume":"386","author":"Hall","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S0140-6736(23)00810-3","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"401","author":"Huang","year":"2023","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jiac.2022.02.024","article-title":"Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers","volume":"28","author":"Ikezaki","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e24325","DOI":"10.1002\/jcla.24325","article-title":"Dynamic observation of SARS-CoV-2 IgM, IgG, and neutralizing antibodies in the development of population immunity through COVID-19 vaccination","volume":"36","author":"Jiang","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"B14","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jiac.2021.01.006","article-title":"Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19","volume":"27","author":"Kutsuna","year":"2021","journal-title":"J. Infect. Chemother."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117390","article-title":"Immunology of SARS-CoV-2 infection and vaccination","volume":"545","author":"Lin","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"B16","doi-asserted-by":"publisher","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","article-title":"More than 50 long-term effects of COVID-19: A systematic review and meta-analysis","volume":"11","author":"Lopez-Leon","year":"2021","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14462","article-title":"Changes of serum IL-10, IL-1beta, IL-6, MCP-1, TNF-alpha, IP-10 and IL-4 in COVID-19 patients","volume":"75","author":"Lu","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"B18","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/oby.23353","article-title":"Antibody responses to BNT162b2 mRNA vaccine: Infection-naive individuals with abdominal obesity warrant attention","volume":"30","author":"Malavazos","year":"2022","journal-title":"Obes. (Silver. Spring)."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12040808","article-title":"Platelet-rich plasma (PRP) in the treatment of long COVID olfactory disorders: A comprehensive review","volume":"12","author":"Maniaci","year":"2024","journal-title":"Biomedicines"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104153","article-title":"Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade","volume":"82","author":"Masia","year":"2022","journal-title":"EBioMedicine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107016","article-title":"Interplay of inflammatory markers and anti-SARS-CoV-2 antibodies in COVID-19 mortality: A prospective cohort study","volume":"143","author":"Mink","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11051279","article-title":"Age, sex and BMI relations with anti-SARS-coV-2-spike igG antibodies after BNT162b2 COVID-19 vaccine in health care workers in northern Greece","volume":"11","author":"Papaioannidou","year":"2023","journal-title":"Microorganisms"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.922422","article-title":"Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome","volume":"12","author":"Queiroz","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMe2103108","article-title":"Interleukin-6 receptor inhibition in covid-19 - cooling the inflammatory soup","volume":"384","author":"Rubin","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12941-023-00594-y","article-title":"The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis","volume":"22","author":"Soheili","year":"2023","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1093\/cid\/ciac722","article-title":"Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae","volume":"76","author":"Swank","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40268-020-00330-3","article-title":"Dosing considerations for antibodies against COVID-19","volume":"21","author":"Tegenge","year":"2021","journal-title":"Drugs R. D."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.1313","article-title":"Comparison of seroconversion in children and adults with mild COVID-19","volume":"5","author":"Toh","year":"2022","journal-title":"JAMA. Netw. Open"},{"key":"B30","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/infdis\/jiac385","article-title":"Comparison of the risk of hospitalization and severe disease among co-circulating severe acute respiratory syndrome coronavirus 2 variants","volume":"227","author":"Trobajo-Sanmartin","year":"2023","journal-title":"J.\u00a0Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2024.04.010","article-title":"Risk of major adverse cardiovascular events after SARS-coV-2 infection in british columbia: A population-based study","author":"Velasquez Garcia","year":"2024","journal-title":"Am. J. Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1096022","article-title":"Effects of vaccines on clinical characteristics of convalescent adult patients infected with SARS-CoV-2 Omicron variant: A retrospective study","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.598799","article-title":"Upregulated IL-6 indicates a poor COVID-19 prognosis: A call for tocilizumab and convalescent plasma treatment","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e214302","DOI":"10.1001\/jamanetworkopen.2021.4302","article-title":"Association of age with SARS-coV-2 antibody response","volume":"4","author":"Yang","year":"2021","journal-title":"JAMA. Netw. Open"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jamaoncol.2021.2159","article-title":"Difference in SARS-coV-2 antibody status between patients with cancer and health care workers during the COVID-19 pandemic in Japan","volume":"7","author":"Yazaki","year":"2021","journal-title":"JAMA. Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40249-023-01086-z","article-title":"Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis","volume":"12","author":"Yin","year":"2023","journal-title":"Infect. Dis. Poverty."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/jmv.25989","article-title":"A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex","volume":"92","author":"Zeng","year":"2020","journal-title":"J. Med. Virol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1477585\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T06:31:56Z","timestamp":1733725916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1477585\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":37,"alternative-id":["10.3389\/fcimb.2024.1477585"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1477585","relation":{},"ISSN":["2235-2988"],"issn-type":[{"type":"electronic","value":"2235-2988"}],"subject":[],"published":{"date-parts":[[2024,12,9]]},"article-number":"1477585"}}